Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities INZY - Inozyme Pharma, Inc.
-53.6 M
LAST VALUE
-50.12%
2 YEAR CAGR
-47.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR